BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23429762)

  • 1. No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Hayashi K; Iwata N; Nakamura J
    Clin Psychopharmacol Neurosci; 2012 Apr; 10(1):49-53. PubMed ID: 23429762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
    Yoshimura R; Kishi T; Suzuki A; Umene-Nakano W; Ikenouchi-Sugita A; Hori H; Otani K; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1022-5. PubMed ID: 21338649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.
    Colle R; Gressier F; Verstuyft C; Deflesselle E; Lépine JP; Ferreri F; Hardy P; Guilloux JP; Petit AC; Fève B; Falissard B; Becquemont L; Corruble E
    J Affect Disord; 2015 Apr; 175():233-40. PubMed ID: 25658497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.
    Umehara H; Numata S; Kinoshita M; Watanabe S; Nakaaki S; Sumitani S; Ohmori T
    Neuropsychiatr Dis Treat; 2016; 12():611-5. PubMed ID: 27042072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Serum Biomarker Levels and BDNF Gene Polymorphism with Response to Selective Serotonin Reuptake Inhibitors in Indian Patients with Major Depressive Disorder.
    Ramesh V; Venkatesan V; Chellathai D; Silamban S
    Neuropsychobiology; 2021; 80(3):201-213. PubMed ID: 32731218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
    Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M
    Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
    Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Katsuki A; Hayashi K; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):308-12. PubMed ID: 20005280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma brain-derived neurotrophic factor (BDNF) concentration and the
    Ai M; Wang J; Chen J; Wang W; Xu X; Gan Y; Li X; Gou X; Cao J; Lv Z; Chen X; Wang H; Ma Q; Kuang L
    Pharmgenomics Pers Med; 2019; 12():97-106. PubMed ID: 31308724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on association of BDNF gene Val66Met polymorphism with efficacy of antidepressants and plasma BDNF level].
    Shen X; Qian M; Yuan Y; Sun J; Zhong H; Yang J; Lin M; Li L; Guan T; Shen Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):196-200. PubMed ID: 24711031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of a brain-derived neurotrophic-factor polymorphism and short-term antidepressant response in major depressive disorders.
    Lin E; Chen PS; Huang LC; Hsu SY
    Pharmgenomics Pers Med; 2008; 1():1-6. PubMed ID: 23226029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression.
    Yoshimura R; Okamoto N; Chibaatar E; Natsuyama T; Ikenouchi A
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.
    Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):722-6. PubMed ID: 19332097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression?
    Vinberg M; Bukh JD; Bennike B; Kessing LV
    Psychiatry Res; 2013 Nov; 210(1):102-8. PubMed ID: 23684538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.
    Katzelnick DJ; Saidi J; Vanelli MR; Jefferson JW; Harper JM; McCrary KE
    Psychiatry (Edgmont); 2006 Dec; 3(12):39-49. PubMed ID: 20877555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatment increased serum miR-183 and miR-212 levels in patients with major depressive disorder.
    Lin CC; Tsai MC; Lee CT; Sun MH; Huang TL
    Psychiatry Res; 2018 Dec; 270():232-237. PubMed ID: 30269040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of serum BDNF levels in late-life depression: Moderated by childhood trauma and SSRI usage?
    Dimitriadis M; van den Brink RHS; Comijs HC; Oude Voshaar RC
    Psychoneuroendocrinology; 2019 May; 103():276-283. PubMed ID: 30771710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome.
    Kang HJ; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    J Affect Disord; 2016 Apr; 194():1-8. PubMed ID: 26795846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure.
    Wang LJ; Chen CK; Hsu HJ; Wu IW; Sun CY; Lee CC
    Neuropsychiatr Dis Treat; 2014; 10():1235-41. PubMed ID: 25045267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.
    Caldieraro MA; McKee M; Leistner-Segal S; Vares EA; Kubaski F; Spanemberg L; Brusius-Facchin AC; Fleck MP; Mischoulon D
    World J Biol Psychiatry; 2018 Aug; 19(5):402-409. PubMed ID: 28656803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.